28080

28080
Arrieta A, Hong JC, Khera R, et al. Updated Cost-effectiveness Assessments of PCSK9 Inhibitors From the Perspectives of the Health System and Private Payers: Insights Derived From the FOURIER Trial. JAMA Cardiol 2017; 2(12):1369–74. DOI: 10.1001/jamacardio.2017.3655. http://www.ncbi.nlm.nih.gov/pubmed/29049467.
Einstellungen
28080
nein
Kategorisierung
Sitemap
nein
Wird geladen
zuletzt verändert: 18.02.2021 | 12:50 Uhr